2-Deoxy-D-Glucose: A Novel Pharmacological Agent for Killing Hypoxic Tumor Cells, Oxygen Dependence-Lowering in Covid-19, and Other Pharmacological Activities
The nonmetabolizable glucose analog 2-deoxy-D-glucose (2-DG) has shown promising pharmacological activities, including inhibition of cancerous cell growth and N-glycosylation. It has been used as a glycolysis inhibitor and as a potential energy restriction mimetic agent, inhibiting pathogen-associat...
Saved in:
Main Authors: | Raman Singh (Author), Vidushi Gupta (Author), Antresh Kumar (Author), Kuldeep Singh (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Silico Evaluation of Binding of 2-Deoxy-D-Glucose with Mpro of nCoV to Combat COVID-19
by: Anirudh Pratap Singh Raman, et al.
Published: (2022) -
2-Deoxy-D-glucose and combined 2-Deoxy-D-glucose/albendazole exhibit therapeutic efficacy against Echinococcus granulosus protoscoleces and experimental alveolar echinococcosis.
by: Qi Xin, et al.
Published: (2022) -
Evidencing leprosy neuronal inflammation by 18-Fluoro-deoxy-glucose.
by: Patricia Sola Penna, et al.
Published: (2023) -
2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update
by: Zoufang Huang, et al.
Published: (2022) -
The Anti-Hypoxic Mechanism of Sesamoside Determined Using Network Pharmacology
by: Dan Song, et al.
Published: (2024)